Activation of Fas receptor modulates cytochrome P450 3A4 expression in human colon carcinoma cells

Young-Jin Chun1, Sungsik Park, Soon Ae Yang

  • 1College of Pharmacy, Chung-Ang University, 221 Huksuk-Dong, Dongjak-Ku, Seoul 156-756, South Korea. yjchun@cau.ac.kr

Toxicology Letters
|November 15, 2003
PubMed

Insights

Fas receptor activation suppresses CYP3A4 expression and induces iNOS in colon cancer cells. This Fas signaling pathway modulation may lead to cellular damage in gastrointestinal tissues.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Fas receptor (CD95, APO-1) is a cell surface receptor mediating apoptosis.
  • Fas activation triggers rapid intracellular signaling pathways.
  • CYP3A4 is a crucial enzyme in drug metabolism and detoxification.

Purpose of the Study:

  • To investigate the impact of Fas receptor activation on CYP3A4 expression in human colon carcinoma HT-29 cells.
  • To explore the role of Fas signaling in regulating iNOS expression and reactive oxygen species generation.

Main Methods:

  • Treatment of HT-29 cells with agonistic anti-Fas antibodies.
  • Measurement of intracellular ceramide levels.
  • Immunoblot analysis for CYP3A4 and iNOS protein expression.
  • Assessment of mRNA expression for CYP3A4.
  • Detection of reactive oxygen species generation.
  • Evaluation of N-acetylcysteine's effect on iNOS induction.

Main Results:

  • Fas activation significantly enhanced intracellular ceramide levels.
  • Fas activation dose-dependently suppressed both CYP3A4 protein and mRNA expression.
  • Anti-Fas antibody treatment significantly stimulated iNOS protein expression.
  • Fas receptor activation increased reactive oxygen species generation.
  • N-acetylcysteine blocked Fas-mediated iNOS induction.

Conclusions:

  • Fas receptor-mediated signaling pathways modulate CYP3A4 expression in human colon cancer cells.
  • Fas activation leads to iNOS induction and CYP3A4 suppression.
  • These combined effects may contribute to toxic cellular damage in gastrointestinal tissues.